Case Reports in Nephrology and Dialysis最新文献

筛选
英文 中文
Familial Hypomagnesemia With Hypercalciuria and Nephrocalcinosis: A Case Report of Compound Heterozygous Variants in the CLDN16 Gene Inherited From Symptomatic Heterozygous Carriers. 家族性低镁血症伴高钙尿和肾钙质沉着症:从症状性杂合携带者遗传的CLDN16基因复合杂合变异体1例报告。
IF 1
Case Reports in Nephrology and Dialysis Pub Date : 2026-10-07 eCollection Date: 2026-01-01 DOI: 10.1159/cnd/abxag006
Monica Ceol, Elena Sgrò, Franca Anglani, Giovanna Priante, Lucia Federica Stefanelli, Martina Cacciapuoti, Leonardo Salviati, Federico Nalesso, Dorella Del Prete
{"title":"Familial Hypomagnesemia With Hypercalciuria and Nephrocalcinosis: A Case Report of Compound Heterozygous Variants in the <i>CLDN16</i> Gene Inherited From Symptomatic Heterozygous Carriers.","authors":"Monica Ceol, Elena Sgrò, Franca Anglani, Giovanna Priante, Lucia Federica Stefanelli, Martina Cacciapuoti, Leonardo Salviati, Federico Nalesso, Dorella Del Prete","doi":"10.1159/cnd/abxag006","DOIUrl":"https://doi.org/10.1159/cnd/abxag006","url":null,"abstract":"<p><strong>Introduction: </strong>Familial hypomagnesemia with hypercalciuria and nephrocalcinosis (FHHNC) is a rare autosomal recessive disorder characterized by renal magnesium wasting, hypercalciuria, and early onset of nephrocalcinosis, complicated by progressive chronic renal failure in childhood or adolescence. The disorder is caused by <i>CLDN16</i> or <i>CLDN19</i> genes' pathogenic variants.</p><p><strong>Case presentation: </strong>We describe a 22-year-old female patient with a clinical diagnosis of FHHNC in infancy. Detailed clinical evaluation revealed a complex phenotype with early nephrocalcinosis, recurrent self-resolving renal colic episodes, persistent hypomagnesemia, and secondary hyperparathyroidism (HPP). High oral doses of magnesium were required to treat the FHHNC, causing significant gastrointestinal side effects, particularly diarrhea, leading to further magnesium losses. Upon transfer to our adult nephrology unit, the proband's blood was subjected to genetic analysis using next-generation sequencing with multigene panel testing.</p><p><strong>Results: </strong>Genetic analysis of the proband revealed compound heterozygous variants in the <i>CLDN16</i> gene: a novel splice-site variant NC_000003.12 (NM_006580.4):c.382+1G>C in the canonical donor splice consensus sequence, classified as likely pathogenic inherited from the mother with HPP phenotype; a rare missense variant NM_006580.4:c.500G>C p.(Trp167Ser) inherited from the father with hypercalciuria. Due to poor tolerability of conventional oral magnesium salts, she was switched to a Sucrosomial magnesium formulation, which significantly improved her gastrointestinal tolerance and adherence.</p><p><strong>Conclusion: </strong>The novel splice-site variant c.382+1G>C and the previously unreported missense variant p.(Trp167Ser) in <i>CLDN16</i> expand the mutational spectrum associated with FHHNC. Regarding the mother's phenotype, a symptomatic carrier of a recessive autosomal disease, our finding suggests the importance of genotype-phenotype analysis in identifying mild forms of FHHNC.</p>","PeriodicalId":9599,"journal":{"name":"Case Reports in Nephrology and Dialysis","volume":"16 1","pages":"162-170"},"PeriodicalIF":1.0,"publicationDate":"2026-10-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13719199/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149295033","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Monoclonal Interstitial Nephritis with IgA-Kappa Plasma Cells Deposition in Sjögren Syndrome: A Case Report. Sjögren综合征单克隆间质性肾炎伴IgA-Kappa浆细胞沉积1例。
IF 1
Case Reports in Nephrology and Dialysis Pub Date : 2026-09-08 eCollection Date: 2026-01-01 DOI: 10.1159/cnd/abxag004
Mario Alamilla-Sanchez, Nicte Alaide Ramos García, Stiven Cardenas Hurtado, Manuel Camacho Luna, Citlali De la Torre García, Regina Canade Hernández Hernández, Carolina Martínez Mijares
{"title":"Monoclonal Interstitial Nephritis with IgA-Kappa Plasma Cells Deposition in Sjögren Syndrome: A Case Report.","authors":"Mario Alamilla-Sanchez, Nicte Alaide Ramos García, Stiven Cardenas Hurtado, Manuel Camacho Luna, Citlali De la Torre García, Regina Canade Hernández Hernández, Carolina Martínez Mijares","doi":"10.1159/cnd/abxag004","DOIUrl":"https://doi.org/10.1159/cnd/abxag004","url":null,"abstract":"<p><strong>Introduction: </strong>In Sjögren syndrome, tubulointerstitial involvement is a frequent finding, characterized by lymphoplasmacytic infiltration, tubular atrophy, and interstitial fibrosis. Nevertheless, descriptions of monoclonal interstitial infiltrates remain scarce. These observations suggest that beyond the classical spectrum of glomerular or tubular injury, a subset of patients with Sjögren syndrome may present atypical renal manifestations potentially associated with underlying monoclonal gammopathy of renal significance. This highlights the importance of accurately characterizing infiltrates and carefully considering monoclonal gammopathy of renal significance (MGRS) as a potential contributor to disease heterogeneity and long-term kidney outcomes.</p><p><strong>Case presentation: </strong>An 83-year-old woman with Sjögren syndrome presented with a rapidly progressive decline in kidney function, without proteinuria. Immunologic and viral workup was unremarkable. A kidney biopsy revealed marked interstitial plasma cell infiltration, as demonstrated by CD138+ staining and IgA-kappa restriction by immunohistochemistry, with no glomerular involvement. Bone marrow evaluation showed <10% plasma cells, excluding multiple myeloma. Serum electrophoresis confirmed an IgA-kappa monoclonal spike and abnormal free light chain ratio. Chemotherapy with bortezomib, dexamethasone, and lenalidomide resulted in an improvement of kidney function and normalization of IgA levels.</p><p><strong>Conclusion: </strong>The interstitium is frequently overlooked in MGRS classification; however, interstitial monoclonal plasma cell infiltration has recently been described in a subgroup of patients with Sjögren syndrome. It may represent a novel entity within MGRS, potentially enhancing prognosis through plasma cell-directed therapies.</p>","PeriodicalId":9599,"journal":{"name":"Case Reports in Nephrology and Dialysis","volume":"16 1","pages":"153-161"},"PeriodicalIF":1.0,"publicationDate":"2026-09-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13688647/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149263078","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Anuric Acute Kidney Injury following a Caffeine Overdose: A Case Report with Biopsy Results. 咖啡因过量后无尿急性肾损伤:一例活检结果报告。
IF 1
Case Reports in Nephrology and Dialysis Pub Date : 2026-09-08 eCollection Date: 2026-01-01 DOI: 10.1159/cnd/abxag003
Kezia T McWhan, Marie H Vrist, Søren P Krag, Bodil G Hornstrup
{"title":"Anuric Acute Kidney Injury following a Caffeine Overdose: A Case Report with Biopsy Results.","authors":"Kezia T McWhan, Marie H Vrist, Søren P Krag, Bodil G Hornstrup","doi":"10.1159/cnd/abxag003","DOIUrl":"https://doi.org/10.1159/cnd/abxag003","url":null,"abstract":"<p><strong>Introduction: </strong>Caffeine can be lethal at approximately 10 g, but overdoses can also cause acute kidney injury (AKI). Some cases of caffeine-induced AKI have been described, but histopathological presentations of this phenomenon, as presented here, are rare. Hemodialysis has been reported in several case studies as a therapeutic option for removal of caffeine and caffeine metabolites.</p><p><strong>Case presentation: </strong>A 43-year-old male suffered AKI after ingesting 10 g caffein pills in an attempted suicide. He was hemodynamically stable. Hemodialysis was initiated to remove caffeine and caffeine metabolites, as the patient was anuric and displayed new-onset QT<sub>c</sub>-prolongation. Hemodialysis was stopped after 14 days, and the patients' renal function gradually fully recovered. Kidney biopsy on day 7 showed mild tubular injury.</p><p><strong>Conclusion: </strong>The case illustrates a rare case of anuric AKI after a caffeine overdose. AKI was fully reversible after treatment with hemodialysis. The kidney biopsy showed mild tubular injury with no clear evidence of myoglobin casts as seen in a previously published case.</p>","PeriodicalId":9599,"journal":{"name":"Case Reports in Nephrology and Dialysis","volume":"16 1","pages":"146-152"},"PeriodicalIF":1.0,"publicationDate":"2026-09-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13688660/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149263155","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Dapagliflozin May Increase Ultrafiltration and Urine Volume in Nondiabetic Peritoneal Dialysis Patients: A Case Series Report. 达格列净可能增加非糖尿病腹膜透析患者的超滤和尿量:一个病例系列报告。
IF 1
Case Reports in Nephrology and Dialysis Pub Date : 2026-07-22 eCollection Date: 2026-01-01 DOI: 10.1159/000552880
Gong Wenjiang, Chen Jia, Yang Jie, Yu Yan, Li Xue, Cheng Yuan, Yani He, Chen Kehong, Huo Bengang, Cai Mingyu
{"title":"Dapagliflozin May Increase Ultrafiltration and Urine Volume in Nondiabetic Peritoneal Dialysis Patients: A Case Series Report.","authors":"Gong Wenjiang, Chen Jia, Yang Jie, Yu Yan, Li Xue, Cheng Yuan, Yani He, Chen Kehong, Huo Bengang, Cai Mingyu","doi":"10.1159/000552880","DOIUrl":"10.1159/000552880","url":null,"abstract":"<p><strong>Introduction: </strong>Reduced ultrafiltration in peritoneal dialysis (PD) contributes to volume overload, increasing the risk of technique failure and patient mortality. The administration of a sodium-glucose cotransporter 2 inhibitor (SGLT2i) has been shown to increase ultrafiltration volume in mice, suggesting its potential role in improving ultrafiltration. However, whether SGLT2i can improve ultrafiltration and increase urine volume in nondiabetic PD patients remains unclear.</p><p><strong>Case presentation: </strong>We report 6 nondiabetic PD patients with a dialysis history of more than 3 months who received 10 mg of dapagliflozin once daily orally for 6 months, in addition to their conventional treatment regimens. After 6 months, clinically significant increases in ultrafiltration were observed (from 76.8 mL at baseline to 211.3 mL), and 5 patients showed increased urine volume (from 433.3 mL to 646.7 mL). The glucose concentration in the effluent dialysate was higher than that at baseline. No changes in peritoneal transport characteristics, estimated glomerular filtration rate, or residual renal creatinine clearance rate were observed at this point compared with baseline. No adverse effects, such as hypoglycemia or abnormal liver function, were reported in any of the patients.</p><p><strong>Conclusions: </strong>In this preliminary observation, dapagliflozin use was associated with increased ultrafiltration and urine volume in nondiabetic PD patients and presented a favorable safety profile. Further controlled studies are needed to confirm these preliminary findings.</p>","PeriodicalId":9599,"journal":{"name":"Case Reports in Nephrology and Dialysis","volume":"16 1","pages":"127-135"},"PeriodicalIF":1.0,"publicationDate":"2026-07-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13592796/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149015732","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Preoperative Therapeutic Plasma Exchange for Severe Hypertriglyceridemia-Associated Myocardial Infarction in a Chronic Hemodialysis Patient Undergoing Urgent Coronary Artery Bypass Grafting: A Case Report. 慢性血液透析患者行紧急冠状动脉旁路移植术治疗重度高甘油三酯血症相关心肌梗死1例
IF 1
Case Reports in Nephrology and Dialysis Pub Date : 2026-07-16 eCollection Date: 2026-01-01 DOI: 10.1159/000553028
Girish Vasudeorao Kumthekar, Aditi Pandey, Amol Kulkarni
{"title":"Preoperative Therapeutic Plasma Exchange for Severe Hypertriglyceridemia-Associated Myocardial Infarction in a Chronic Hemodialysis Patient Undergoing Urgent Coronary Artery Bypass Grafting: A Case Report.","authors":"Girish Vasudeorao Kumthekar, Aditi Pandey, Amol Kulkarni","doi":"10.1159/000553028","DOIUrl":"https://doi.org/10.1159/000553028","url":null,"abstract":"<p><strong>Introduction: </strong>Severe hypertriglyceridemia (HTG) is a well-recognized cause of acute pancreatitis, but its role as a precipitant of acute myocardial infarction (MI) and a barrier to urgent surgical intervention is less frequently documented, especially in patients with end-stage renal disease (ESRD).</p><p><strong>Case presentation: </strong>We report a unique case of a 68-year-old male on chronic hemodialysis who presented with an inferior wall MI. Coronary angiography revealed severe triple vessel disease necessitating urgent coronary artery bypass grafting (CABG). However, laboratory investigations identified critical HTG (1,943 mg/dL), posing significant risks for hyperviscosity and extracorporeal circuit failure. To mitigate these perioperative risks, the patient underwent four sessions of preoperative therapeutic plasma exchange (TPE), which successfully reduced serum triglycerides to 355 mg/dL. Following this stabilization, the patient underwent a successful off-pump CABG and was managed postoperatively with sustained low-efficiency dialysis.</p><p><strong>Conclusion: </strong>This case highlights the clinical utility of TPE as a rapid and effective \"therapeutic bridge\" to enable safe, urgent cardiac surgery in patients with severe HTG. It demonstrates that preoperative lipid-lowering aphaeresis can safely manage metabolic barriers to surgery in complex ESRD patients, potentially expanding the management options for high-risk cardiovascular cases where medical therapy alone is insufficient.</p>","PeriodicalId":9599,"journal":{"name":"Case Reports in Nephrology and Dialysis","volume":"16 1","pages":"119-126"},"PeriodicalIF":1.0,"publicationDate":"2026-07-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13493112/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148788629","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Dialysis Disequilibrium Syndrome: A Severe Case with Neurologic Recovery - A Case Report. 透析不平衡综合征:严重神经系统恢复1例报告。
IF 1
Case Reports in Nephrology and Dialysis Pub Date : 2026-07-03 eCollection Date: 2026-01-01 DOI: 10.1159/000553357
Ewalola Ayo Ijaduola, Sana Waheed, Khalid Bashir
{"title":"Dialysis Disequilibrium Syndrome: A Severe Case with Neurologic Recovery - A Case Report.","authors":"Ewalola Ayo Ijaduola, Sana Waheed, Khalid Bashir","doi":"10.1159/000553357","DOIUrl":"https://doi.org/10.1159/000553357","url":null,"abstract":"<p><strong>Introduction: </strong>Dialysis disequilibrium syndrome is a serious complication occurring during hemodialysis initiation and after a break from hemodialysis, with a myriad of neurological symptoms.</p><p><strong>Case presentation: </strong>We report a case of a 68-year-old woman with a history of hypertension, type 2 diabetes mellitus, and recently diagnosed end-stage kidney disease. She presented to the emergency room with disorientation and hypertensive urgency and had started hemodialysis 3 months prior but declined further treatment. Laboratory data revealed blood urea nitrogen of 151 mg/dL, creatinine of 18 mg/dL, bicarbonate level of 5 mEq/L, and potassium of 6.6 mEq/L. A temporary hemodialysis catheter was inserted, and dialysis was initiated with a blood flow rate of 300 mL/min and a dialysate flow rate of 600 mL/min, using an Optiflux 180NRe dialyzer (surface area 1.7 m<sup>2</sup>) for a duration of 3 h. The patient developed seizure activity after 2 h and 55 min, described as tonic-clonic seizure lasting 5 min. The urea reduction ratio was 57.6%, and the bicarbonate level increased from 5 to 16 mEq/L. She remained in a stuporous state, with no response to stimuli. She was transferred to the intensive care unit and received 20% mannitol 0.5 g/kg (40 g), followed by 3% hypertonic saline (30 mL bolus, then 50 mL/h infusion), with the aim of maintaining a serum sodium concentration between 145 and 155 mEq/L. Forty-eight hours later, she began to open her eyes to voice and consistently followed commands.</p><p><strong>Conclusion: </strong>Our patient's dialysis disequilibrium syndrome severity correlated with the urea reduction ratio and severe metabolic acidosis, highlighting the importance of achieving a low urea reduction ratio (<40%) and a targeted rise in bicarbonate levels, both of which are risk factors for dialysis disequilibrium syndrome. In addition, the use of 3% saline and mannitol is an important preventive and rescue strategy.</p>","PeriodicalId":9599,"journal":{"name":"Case Reports in Nephrology and Dialysis","volume":"16 1","pages":"113-118"},"PeriodicalIF":1.0,"publicationDate":"2026-07-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13480977/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148788609","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Simultaneous Appearance of Immunoglobulin A Nephropathy and Tubulointerstitial Nephritis and Uveitis Syndrome: A Case Report. 免疫球蛋白A肾病与小管间质性肾炎及葡萄膜炎综合征同时出现1例报告。
IF 1
Case Reports in Nephrology and Dialysis Pub Date : 2026-06-18 eCollection Date: 2026-01-01 DOI: 10.1159/000552832
András Adámy, Selina Berger, Jan Brügger, Manuela Nickler
{"title":"Simultaneous Appearance of Immunoglobulin A Nephropathy and Tubulointerstitial Nephritis and Uveitis Syndrome: A Case Report.","authors":"András Adámy, Selina Berger, Jan Brügger, Manuela Nickler","doi":"10.1159/000552832","DOIUrl":"https://doi.org/10.1159/000552832","url":null,"abstract":"<p><strong>Introduction: </strong>Immunoglobulin A (IgA) nephropathy usually occurs after upper respiratory tract infection. The currently widely accepted pathomechanism involves genetic predisposition, formation of galactose-deficient IgA1, and production of autoantibodies against these IgA, ultimately leading to mesangial deposition of immune complexes. Tubulointerstitial nephritis and uveitis (TINU) syndrome is a rare disease with a suspected autoimmune mechanism, although the exact etiology and pathomechanism are not fully understood. To our knowledge, only a few cases with simultaneous occurrence of these two entities have been reported in common literature so far.</p><p><strong>Case presentation: </strong>A 53-year-old Ethiopian woman presented with a month of postprandial nausea, vomiting, occipital headache, 5 kilogram weight loss and intermittent night sweats. Laboratory examinations revealed hematuria and impaired renal function, histological findings showed acute tubulointerstitial nephritis and glomerulonephritis. Further assessments revealed left-sided anterior uveitis as well as a <i>Helicobacter pylori</i> and <i>Strongyloides</i> infection. We present the case of a middle-aged woman with concurrent IgA nephropathy and TINU syndrome, possibly following a <i>H. pylori</i> and <i>Strongyloides</i> infection. There was rapid and significant improvement of renal disease after glucocorticoid treatment.</p><p><strong>Conclusion: </strong>Further research is needed to elucidate possible causality between IgA nephropathy, TINU syndrome, and the potential trigger factors involved.</p>","PeriodicalId":9599,"journal":{"name":"Case Reports in Nephrology and Dialysis","volume":"16 1","pages":"106-112"},"PeriodicalIF":1.0,"publicationDate":"2026-06-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13476060/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148757637","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Successful Kidney Transplantation in a Patient with Genetic Hypertension due to a Pathogenic Kelch-Like 3 Mutation: A Case Report. 因致病性kelch样3突变导致的遗传性高血压患者肾移植成功一例报告。
IF 1
Case Reports in Nephrology and Dialysis Pub Date : 2026-05-25 eCollection Date: 2026-01-01 DOI: 10.1159/000552690
Tito Gianni, Hatem Najar, Kiran M Goli, Fitsum T Hailemariam, Maria P Martinez Cantarin, Maitreyee Gupta
{"title":"Successful Kidney Transplantation in a Patient with Genetic Hypertension due to a Pathogenic Kelch-Like 3 Mutation: A Case Report.","authors":"Tito Gianni, Hatem Najar, Kiran M Goli, Fitsum T Hailemariam, Maria P Martinez Cantarin, Maitreyee Gupta","doi":"10.1159/000552690","DOIUrl":"10.1159/000552690","url":null,"abstract":"<p><strong>Introduction: </strong>Gordon syndrome (or pseudohypoaldosteronism type II) is a rare form of hyperkalemic, hyperchloremic hypertension that is typically characterized by preserved kidney function. We report the first case of a successful paired exchange kidney transplant in a patient with an atypical presentation of Gordon syndrome due to a pathogenic KLHL-3 mutation who developed end-stage kidney disease, emphasizing the transplant outcomes and renal function.</p><p><strong>Case presentation: </strong>A 24-year-old Caucasian male with early-onset hypertension since the age of 15 years, intermittent hyperkalemia, and non-adherence to thiazide diuretics was admitted with abdominal pain and vomiting. His family history included early-onset hypertension in his brother, father, and paternal grandmother. His blood pressure was 250/160 mm Hg. The laboratory results revealed a creatinine of 9.9 mg/dL, potassium of 3.0 mmol/L, sodium of 136 mmol/L, chloride of 91 mmol/L, bicarbonate of 18 mmol/L, hemoglobin of 10 g/dL, and platelet count of 87,000/μL. Renal ultrasound indicated increased echogenicity in both kidneys, and a glomerulonephritis workup was negative. Despite the use of aggressive antihypertensive therapy, progressive azotemia required hemodialysis. A kidney biopsy showed severe vascular and tubulointerstitial changes, consistent with hypertensive nephrosclerosis. Genetic testing confirmed a heterozygous pathogenic variant in the KLHL-3 gene, diagnosing Gordon syndrome. Five months later, the patient underwent successful living-unrelated kidney transplantation via a paired exchange program. Early post-transplant complications included acute allograft dysfunction due to volume depletion and mild hydronephrosis, which improved with timely intervention, stabilizing creatinine at 1.1-1.2 mg/dL. The patient also developed severe post-transplant anemia secondary to parvovirus B19 infection, which was successfully treated with intravenous immunoglobulin, erythropoiesis-stimulating agents, and blood transfusions. At follow-up, the patient showed excellent allograft function and well-controlled blood pressure on a simplified antihypertensive regimen.</p><p><strong>Discussion and conclusions: </strong>This case highlights an unexpected manifestation of an exceptionally rare disease, Gordon syndrome, due to a pathogenic KLHL-3 variant, uniquely leading to end-stage kidney disease and subsequent kidney transplantation. The impact of pathogenic KLHL-3 mutations on transplant outcomes remains undefined. However, our patient underwent kidney transplantation, resulting in excellent renal allograft function and optimal blood pressure control, thus demonstrating favorable renal transplant outcomes for patients with genetic hypertension.</p>","PeriodicalId":9599,"journal":{"name":"Case Reports in Nephrology and Dialysis","volume":"16 1","pages":"90-99"},"PeriodicalIF":1.0,"publicationDate":"2026-05-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13354286/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148419042","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Neither Therapeutic Plasma Exchange nor High-Flux Hemodialysis Enhances the Removal of Chlorprothixene in Case of Intoxication despite a Drop in Plasma Levels: A Case Report. 治疗性血浆置换和高通量血液透析都不能增强中毒病例中氯丙噻烯的去除,尽管血浆水平下降:一个病例报告。
IF 1
Case Reports in Nephrology and Dialysis Pub Date : 2026-05-21 eCollection Date: 2026-01-01 DOI: 10.1159/000551514
Maj-Britt Nachtigall, Stephan Scherneck, Bastian Au, Christian Hansen-Hagge, Jan T Kielstein
{"title":"Neither Therapeutic Plasma Exchange nor High-Flux Hemodialysis Enhances the Removal of Chlorprothixene in Case of Intoxication despite a Drop in Plasma Levels: A Case Report.","authors":"Maj-Britt Nachtigall, Stephan Scherneck, Bastian Au, Christian Hansen-Hagge, Jan T Kielstein","doi":"10.1159/000551514","DOIUrl":"10.1159/000551514","url":null,"abstract":"<p><strong>Introduction: </strong>Chlorprothixene is a typical antipsychotic, primarily used in the treatment of psychotic disorders. Overdose may result in severe cardiovascular and central nervous system toxicity. Evidence on the effectiveness of extracorporeal elimination is scarce.</p><p><strong>Case presentation: </strong>A 19-year-old female ingested 5 g of chlorprothixene in a suicide attempt. Upon admission to the intensive care unit, she was awake, responsive, and oriented. Initial management included 50 g of activated charcoal. As doses of >2 g chlorprothixene can cause severe intoxication and death, attempts to enhance drug elimination by extracorporeal therapy were undertaken. Therapeutic plasma exchange (TPE) was initiated approximately 3 h after admission, exchanging 5,096 mL of plasma with albumin solution and FFP over 3 h 10 min. This was followed by a 10 h 10 min prolonged intermittent kidney replacement therapy (PIKRT). Serial blood, apheresis, and dialyzate samples were collected to quantify drug removal. Both procedures were well tolerated. The patient remained clinically stable and was transferred to a psychiatric facility 24 h post-admission.</p><p><strong>Conclusion: </strong>Although chlorprothixene plasma levels decreased, the amount of chlorprothixene removed by TPE and PIKRT was negligible, classifying the drug as \"not dialyzable\" per EXTRIP criteria. Given the limited clinical evidence and the pharmacokinetic properties of chlorprothixene, TPE cannot be recommended for the management of chlorprothixene overdose and should not be regarded as a standard treatment option. According to the available literature, this is the first description of chlorprothixene intoxication managed with both TPE and high-flux hemodialysis, highlighting the limited extracorporeal removal of this drug.</p>","PeriodicalId":9599,"journal":{"name":"Case Reports in Nephrology and Dialysis","volume":"16 1","pages":"69-74"},"PeriodicalIF":1.0,"publicationDate":"2026-05-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13263003/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148249185","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Transplant Renal Artery Stenosis Presenting as Posterior Reversible Encephalopathy Syndrome in a Post-Kidney Transplant Patient: A Case Report. 肾移植后肾动脉狭窄表现为后部可逆性脑病综合征:一例报告。
IF 1
Case Reports in Nephrology and Dialysis Pub Date : 2026-05-19 eCollection Date: 2026-01-01 DOI: 10.1159/000552595
Mihiran Thanigasalan, Thivacaren Sritharan, Mehatheepan Rasanayagam, Anura Priyantha Hewageegana
{"title":"Transplant Renal Artery Stenosis Presenting as Posterior Reversible Encephalopathy Syndrome in a Post-Kidney Transplant Patient: A Case Report.","authors":"Mihiran Thanigasalan, Thivacaren Sritharan, Mehatheepan Rasanayagam, Anura Priyantha Hewageegana","doi":"10.1159/000552595","DOIUrl":"10.1159/000552595","url":null,"abstract":"<p><strong>Introduction: </strong>Transplant renal artery stenosis (TRAS) is a reversible cause of severe hypertension and graft dysfunction. Posterior reversible encephalopathy syndrome (PRES) in kidney transplant recipients is commonly attributed to calcineurin inhibitor (CNI) toxicity; however, the biochemical signatures of CNI toxicity and TRAS differ markedly.</p><p><strong>Case presentation: </strong>We report a 32-year-old woman, 5 months post-transplant, presenting with seizures, severe hypertension, and MRI-confirmed PRES. She exhibited hypokalaemia (2.6 mmol/L) and metabolic alkalosis (pH 7.50, bicarbonate 34 mmol/L) - findings less typical of tacrolimus toxicity, which more typically produces a Gordon-like physiology with hyperkalaemia and metabolic acidosis due to excess activity of the NCC (Na-Cl cotransporter). Doppler ultrasound and digital subtraction angiography confirmed TRAS. Percutaneous angioplasty resulted in rapid renal recovery.</p><p><strong>Conclusion: </strong>PRES with hypokalaemia should prompt evaluation for renovascular hypertension rather than tacrolimus toxicity.</p>","PeriodicalId":9599,"journal":{"name":"Case Reports in Nephrology and Dialysis","volume":"16 1","pages":"100-105"},"PeriodicalIF":1.0,"publicationDate":"2026-05-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13354283/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148419060","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书